Devyser Wins SEK 5.7M Milan Tender, Doubling Test Volumes
Devyser won a renewed three-year tender with Milan’s IRCCS Ca' Granda Policlinico for Devyser Thalassemia and Amplicon Suite. The tender is valued at about SEK 5.7 million and runs from 1 September 2026 to 31 August 2029, with a possible three-year extension.
Devyser secured a renewed 3-year tender with IRCCS Ca' Granda Policlinico in Milan for Devyser Thalassemia and Amplicon Suite. The tender is valued at ~SEK 5.7M, and test volumes are doubling versus the prior period. The agreement runs from 1 Sep 2026 to 31 Aug 2029 and may be extended by three years.